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ABSTRACT The traditional approach to investigating the partial unfolding and ﬁbrillation of insulin, and proteins at large, has
involved use of the dyes 1-anilinonaphthalene-8-sulphonic acid (ANS) and Thioﬂavin T (ThT), respectively. We compare the
kinetic proﬁles of ThT, ANS, light scattering, and intrinsic Tyr ﬂuorescence during insulin ﬁbrillation. The data reveal that the
sequence of structural changes (dimers / monomers / partially unfolded monomers / oligomeric aggregates / ﬁbrils)
accompanying insulin ﬁbrillation can be detected directly using intrinsic Tyr ﬂuorescence. The results indicate that at least
two distinguishable structural intermediates precede ﬁbril development. There is no evidence of tyrosinate or dityrosine during
insulin aggregation. Obtaining such critical information from the protein itself is complementary to existing aggregation probes
and affords the advantage of directly examining structural changes that occur at the molecular level, providing concrete details
of the early events preceding ﬁbrillation.INTRODUCTION
It is now accepted in the literature that under appropriate
solution conditions, proteins have an inherent property of
misfolding and forming fibrillar aggregates (1,2). The
fibrils so formed are thermodynamically stable and rich in
b-sheets. Understanding protein aggregation is of critical
importance to a wide variety of biomedical situations
ranging from conformational disorders (such as Alzheimer’s
disease and cataracts) (3) to the production, stability, and
delivery of protein-based pharmaceuticals including insulin
and immunoglobulin G (4). Surprisingly, the molecular
mechanism underlying protein aggregation is still not fully
understood.
Insulin is a 51-residue peptide-hormone involved in the
homeostasis of blood glucose levels. It is composed of two
peptide chains, A and B, of 21 and 30 amino acid residues,
respectively (5). The A-chain contains an intrachain cystine
bridge between residues A6 and A11 and is covalently linked
to the B-chain via two interchain cystine bridges, A7–B7 and
A20–B19 (6). The peptide-hormone derives its stability from
these strongly hydrophobic cystine groups (7). The sec-
ondary structure of native insulin is reported to be 58%
a-helical with a 6% b-sheet region (8). The helical segments
span residues A1–A9 and A12–A19 of the A chain, and B9–B19
of the B chain (9–11). Other studies suggest an additional,
phenol-promoted helix spanning residues B1–B8 (12). In
solution, insulin has the unique trait of assuming different
association states, including dimers, tetramers, and hexamers
(13). The various association states are dependent on the
overall net charge on the protein and hence are dictated by
the solution pH. Insulin is hexameric at physiological pH,
dimeric in mineral acids, including HCl, and monomeric in
20% acetic acid (6,13). Insulin is conformationally flexible
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under acidic conditions (14).
Since its discovery in 1921, insulin has been isolated and
produced in commercial quantities to treat insulin-dependent
diabetics (15). A major problem confronting the industry is
insulin aggregation during processing and delivery of the
protein-drug. Conventional processing of insulin involves
exposure of the peptide-hormone to agitation, low pH, and
varying shear rates (during filtration, pumping, and centri-
fugation), as well as to an array of interfaces during admin-
istration (4,16). These conditions are known to facilitate
conformational destabilization, leading to partial unfolding
and subsequent coalescence of insulin into amorphous and/
or fibrillar aggregates (17). Indeed, amyloid plaques have
been observed in insulin-dependent diabetics after repeated
administration of insulin (18) and in normal aging (19).
The abnormal folding and association of a protein into
fibrous aggregates is not unique to insulin. This phenomenon
has been reported for a range of polypeptides and has
received considerable attention in research (20,21). It is pro-
posed that insulin aggregation proceeds through the dissoci-
ation of oligomeric states into monomers, which then
undergo conformational changes and reassociate into stable,
fibrous amyloid aggregates rich in b-sheets (22). It is thought
that the coalescence of partially folded monomers and the
emergence of fibrillar insulin is driven primarily by hydro-
phobic interactions (6,17). An in-depth knowledge of the
key steps and contributors to protein aggregation is crucial
for the development of therapeutic drugs to circumvent
conformational disorders, and will also inform the design
of quality control systems in industry to ensure the stability
of the physical and chemical integrity of protein products
during processing, transportation, and storage.
The traditional approach to investigating the partial
unfolding and fibrillation of insulin, and of proteins at large,
has involved use of the dyes 1-anilinonaphthalene-8-sul-
phonic acid (ANS) and Thioflavin T (ThT), respectively.
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emission lmax at 460 nm upon excitation at 350 nm and has
been successfully applied to show that a partially folded
intermediate state precedes fibril formation (23). Thioflavin
T, on the other hand, is known to associate rapidly with
multimeric b-sheet-containing amyloid fibrils, showing
enhanced emission at 482 nm upon excitation at 450 nm
(24,25). Although these dyes have proven instrumental in
our understanding of protein aggregation, their mode of
action and possible contribution to the aggregation process
has yet to be fully understood. For this reason, it is essential
to apply an array of complementary techniques when
studying the complexities of the structural changes that
accompany protein aggregation.
Intrinsic protein fluorescence is a sensitive technique that
has been exploited in studying the structural, physicochem-
ical, and functional properties of proteins (26). Proteins
derive their intrinsic fluorescence from the chromophores
phenylalanine, tyrosine, and tryptophan (27). Bovine insulin
contains four Tyr and three Phe residues. In the absence of
Trp, Tyr dominates the absorption spectrum of proteins to
the exclusion of Phe and nonaromatic absorption attributable
to cystine, histidine, or the peptide bond (28). It has been
found that protein denaturation results in marked uniformity
in its fluorescence characteristics (29), and that is what we
expected for insulin under the experimental conditions
used in this study. We observe a sigmoid in Tyr fluorescence
during insulin aggregation; hence, the focus of this work was
to investigate the physical and chemical transformations
associated with insulin aggregation by means of its intrinsic
fluorescence. Multiple probes were employed to better
understand the molecular dynamics involved in the process
as indicated by intrinsic Tyr fluorescence.
MATERIALS AND METHODS
Materials
Bovine insulin and ThT were obtained from Sigma (St. Louis, MO). The
hydrophobic probe ANS was purchased from Aldrich (Milwaukee, WI).
All other reagents used were of analytical grade.
Sample preparation
Insulin solutions were prepared by dissolving the peptide directly in 0.1%
(v/v) HCl (pH 1.9) to give a concentration of ~0.2 mg/mL. The final insulin
concentration was calculated from ultraviolet (UV) absorption at 280 nm,
applying a molar extinction coefficient of 5.53 mM1 cm1. For insulin/
dye samples, 1-mM stocks of ThT and ANS were prepared by dissolving
each dye in double-distilled water and then filtering through a 0.22-mm filter
paper. The final dye concentration in insulin samples was 50 mM.
Fluorescence spectroscopy
Fluorescence studies were conducted using a Cary Eclipse fluorescence
spectrophotometer (Varian, Palo Alto, CA) equipped with a Peltier unit
for stirring and temperature control. All measurements were obtained using
a 1-cm quartz cuvette equipped with a 5-mm magnetic stirrer bar (spin rate,
~120 rpm). Multiple wavelengths were used simultaneously to study bothBiophysical Journal 97(9) 2521–2531intrinsic (Tyr) and extrinsic (ThT/ANS) fluorescent probes during insulin
aggregation. For insulin fibrillation, 3 mL of a reaction sample was incu-
bated at 60C over a period of 22 h. Intrinsic insulin fluorescence was
monitored via Tyr molecules using an excitation wavelength of 276 nm,
with emission measured at 303/305 nm (kinetic studies), or 280–500 nm
(interval scans). Tyrosinate and dityrosine fluorescence were measured
using excitation/emission wavelengths of 295/345 nm and 315/410 nm,
respectively. ThT fluorescence emission was measured at 482 nm on excita-
tion at 450 nm, whereas ANS fluorescence was probed using excitation and
emission wavelengths of 350 nm and 460 nm, respectively.
Light scattering
Real-time light scattering was measured during bovine insulin aggregation
using the fluorimeter described above. The excitation wavelength was set
at 600 nm, away from the absorption regions of the chromophores present,
and scattered light was measured at 605 nm (shoulder of excitation peak).
The data were collected at 5-min intervals using excitation and emission
slit widths of 10 nm unless stated otherwise.
Data analysis
Fluorescence and CD data were further analyzed using phase diagrams as
described elsewhere (30,31).
Atomic force microscopy
Imaging of insulin fibrils was done using an Asylum MFP 3D atomic force
microscope (AFM) (Santa Barbara, CA). Aliquots (20 mL) from insulin
samples incubated at 60C, with stirring for 22 h, were applied to a freshly
cleaved mica surface. A time frame of 30 min was allowed for the protein to
fix onto the mica. Excess protein solution on mica was rinsed off thoroughly
under running MilliQ water and air-dried in a laminar flow cabinet. Imaging
was done in air, under ambient conditions, using silicon nitride probes in
intermittent contact mode.
Secondary structure of insulin ﬁbrils
Far-UV circular dichroism (CD) spectra of fibrillated insulin samples were
recorded at room temperature using a Jasco J-815 CD spectrometer (Tokyo,
Japan). A 100-mL aliquot of insulin preparations incubated at 60C, with
stirring for 22 h, was scanned in a 0.2-cm quartz cell from 195 to 240 nm.
Solvent spectrum was used as the baseline for data collection. The final
spectrum of all samples was an average of three independent scans.
Thermal denaturation/renaturation experiments
The effect of temperature on insulin structure was studied by fluorescence
and CD spectroscopy; conducted over a temperature range of 10–95C using
a temperature gradient of 5C. The concentration of insulin used was
~0.2 mg/mL in all experiments. For intrinsic fluorescence studies, emission
scans of Tyr molecules were recorded from 280 to 500 nm in a 1-cm quartz
cell using an excitation wavelength of 276 nm. CD spectra for both near- and
far-UV were recorded using a Jasco J-815 CD spectrometer. Insulin samples
(200 mL) were scanned in a 0.2-cm cell from 195 to 340 nm using a data
interval of 0.1 nm, a bandwidth of 1.0 nm, a response time of 4 s, and a scan-
ning speed of 50 nm/min. Both fluorescence and CD data were collected
after a delay time of 5 min at each temperature.
RESULTS
The kinetics of insulin denaturation, aggregation, and subse-
quent fibrillation as detected by multiple parameters were
normalized to unity (Fig. 1). The amyloid probe ThT and
Bovine Insulin Fibrillation 2523ANS were employed to detect fibril development and
solvent-exposed hydrophobic groups, respectively, during
insulin aggregation. Light scattering was used to detect
the increase in particle size (aggregates) in solution, and
intrinsic Tyr fluorescence provided a means to study the
physicochemical changes associated with insulin fibrillation.
Reaction samples were incubated at 60C and stirred contin-
uously at ~120 rpm for 22 h, after which ThT assays, AFM
images, and CD spectra confirmed the presence of amyloid
fibrils.
Kinetics of insulin aggregation/ﬁbrillation
The kinetic profile of ThT shows typical sigmoidal behavior
indicative of a nucleation-dependent fibril assembly
proceeding in three phases (8): 1), a lag phase, during which
a fibril-competent nucleus evolves; 2), a growth phase, with
rapid polymerization of amyloidogenic nuclei into fibrils;
and 3), an equilibrium phase, in which the fibrils mature.
The validity of this mechanism of insulin fibrillation is
supported by data obtained from complementary studies
described below.
A dramatic increase in ANS fluorescence and quenching
of Tyr fluorescence was observed to occur in sync at ~2 h
of incubation, both reaching equilibrium after 8 h. The two
profiles were obtained simultaneously from an insulin-
ANS sample. The fluorescence enhancement of ANS at
460 nm indicates the presence of solvent-exposed hydro-
phobic regions, originating from partially folded intermedi-
ates in solution. The concurrent decrease in Tyr fluorescence
suggests that Tyr residues were within hydrophobic pockets
in the protein matrix and became accessible to effective
quenchers upon exposure to the aqueous environment.
FIGURE 1 Kinetics of insulin fibrillation detected by multiple parame-
ters. Insulin denaturation and subsequent fibrillation were detected by
changes in the fluorescence emission of ThT (open triangles), Tyr (open dia-
monds), ANS (open squares), and light scattering (solid line). The experi-
ments were done in 0.1% HCl (pH 1.9) at 60C, with continuous stirring
at 120 rpm.Indeed, Tyr-A14, Tyr-B16, and Tyr-B26 are resident in the
two hydrophobic faces of the insulin monomer that associate
to form dimers (32); and the emission intensity at 305 nm is
an average of the parametric changes affecting the micro-
environment of all Tyr residues. It is worth noting that the
lag times for these changes terminated ~3 h before the onset
of ThT fluorescence enhancement at 482 nm, which shows
that partially folded intermediates indeed precede insulin
fibrillation.
The light-scattering profile shows the gradual develop-
ment of large aggregates (oligomers) in solution from the
onset of incubation, with a dramatic increase occurring after
~3 h. This clearly shows that the early insulin aggregates
formed, although light-scattering, escape detection by ThT.
The data also reveal that the partially folded intermediates,
which begin to evolve after ~2 h incubation, associate
rapidly into these oligomers from which fibrillar aggregates
develop. The occasional spikes experienced in the kinetic
trace are attributable to the polydispersed nature of insulin
aggregates formed during fibrillation (33,34).
The observed intrinsic Tyr fluorescence profile during
insulin fibrillation, relative to those of ThT and ANS,
informed the design of an experimental approach to study
insulin fibrillation via its intrinsic fluorescence.
Insulin ﬁbril morphology and secondary structure
AFM height traces of insulin fibrils formed in the presence or
absence of dyes is shown in Fig. 2, a–c. A dense network of
fibrils is observed in all cases, consistent with that reported
elsewhere (6). The crowded nature of the fibril network
made it difficult to measure heights of individual fibrils rela-
tive to the mica surface. However, it is clear by visualizing
that fibrils formed in the absence of a dye were thinner
than those formed in the presence of ThT or ANS. This
observation suggests variations in fibril morphology. The
images were made in the order in which they are presented,
hence dispelling the possible introduction of an artifact, for
example, tip broadening of measured lateral dimensions.
Complementary studies using electron microscopy gave
similar results (data not shown).
The far-UV spectra of insulin samples incubated for 22 h
at 60C in the presence and absence of ThT/ANS are shown
in Fig. 2 b. All three spectra were characteristic of b-sheet
secondary structure, but with noticeable differences in trace
and minimum ellipticity, depending on the dye present. The
spectra obtained for dye-free insulin and insulin-ThT both
showed minimum ellipticity at 220 nm, whereas that
obtained for insulin-ANS had its peak negative intensity at
222 nm. These minima show a red shift from the character-
istic b-sheet signature, which occurs between 215 nm and
218 nm. The occurrence of this feature can be ascribed to
residual helical structure in fibrillar insulin, possibly origi-
nating from the B-chain helix (30). It is also possible that
the observed differences are a consequence of insulin-dyeBiophysical Journal 97(9) 2521–2531
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ary structure of fibrillated insulin.
(a–c) AFM height trace images
comparing insulin fibrils formed in the
presence of ThT (a) and ANS (b) and
in the absence of a dye (c). The images
show variations in fibril morphology
depending on the dye present. Scale
bars, 1 mm. (Lower) Far-UV spectra of
insulin fibrils at pH 1.9. The spectra
represent fibrils formed in the presence
of ThT (:::) and ANS (B), and
in the absence of a dye (dash-dotted
line). The data were collected at
ambient temperature, and each trace is
an average of three independent scans.interactions leading to polymorphisms in the resulting fibril
structure.
Monitoring insulin ﬁbrillation via Tyr ﬂuorescence
At ambient temperature, intrinsic Tyr fluorescence of insulin
preparations (see Materials and Methods) showed an emis-
sion lmax at 305 nm with two excitation peaks at 276 nm
and 227 nm. This indicates that the freshly prepared reaction
solutions did not contain hydrogen-bonded Tyr residues.
Two approaches were used to monitor changes in Tyr
fluorescence for a dye-free insulin sample incubated under
conditions favoring fibrillation. The aim was to explain the
Tyr fluorescence quenching observed during insulin aggre-
gation by probing the possible chemical modifications the
fluorophore may access. The first method was to conduct
interval scans of the emission spectrum during insulin aggre-
gation (Fig. 3 a). The insulin sample was excited at 276 nm,
with emission scans from 280–500 nm at 5-min intervals
(1-h interval scans are shown for clarity). The scans show
a decrease in Tyr fluorescence intensity during insulin fibril-
lation. This becomes apparent on plotting the emission inten-
Biophysical Journal 97(9) 2521–2531sity at 305 nm against time (Fig. 3 a, inset), which gives
a sigmoid curve similar to that of the Tyr fluorescence profile
in Fig. 1. The data were further analyzed using phase
diagrams, which have proven versatile in detecting interme-
diate states of a protein undergoing structural transition from
an initial to a final state (35). A plot of the emission intensity
I330nm against I305nm from the fluorescence data (Fig. 3 b)
shows three linear segments spanning 0–3 h, 3–12 h, and
12–22 h. Each segment describes a distinctive structural tran-
sition, revealing the existence of four structurally unique
species during insulin fibrillation. Using information gath-
ered from Fig. 1, we identify the structural species involved
as 1), the initial mix of monomers and dimers; 2), partially
unfolded intermediates/oligomers; 3), protofibrillar aggre-
gates; and 4), mature fibrils. This observation is consistent
with the proposal that structural transitions accompany
insulin fibrillation (22,23,36).
The second approach involved monitoring Tyr fluores-
cence at fixed wavelengths (see the Supporting Material).
This allowed simultaneous studies of changes in Tyr fluores-
cence (excitation 276 nm, emission 305 nm) and the possible
formation of tyrosinate (excitation 295 nm, emission
Bovine Insulin Fibrillation 2525345 nm) and/or dityrosine (excitation 315 nm, emission 410
nm) during insulin aggregation. The intrinsic Tyr fluores-
cence kinetic profile showed the familiar sigmoid curve
(Fig. S1 a in the Supporting Material). There was no signif-
icant change in the emission intensity at the wavelengths
associated with tyrosinate and dityrosine over the 22-h
period (Fig. S1, b and c). The phenol group of Tyr has
a pKa of 9.8 and 4.2 for the ground and excited states,
respectively (37). At pH 1.9, the phenol group of Tyr and
its possible proton acceptors, including Glu and Asp resi-
dues, are fully protonated, which explains the absence of
tyrosinate, and hence dityrosine, during insulin aggregation.
It is noteworthy that the position and shape of the emission
FIGURE 3 Insulin denaturation/fibrillation detected by Tyr fluorescence.
(a) Fluorescence emission spectra of tyrosine during insulin aggregation.
The insulin sample (0.2 mg/mL) was excited at 276 nm, with emission scans
from 280 to 500 nm. The figure shows a consistent decrease in intensity of
the emission lmax (305 nm) after ~2 h of incubation, reaching equilibrium
after 12 h. (Inset) A sigmoid is observed on plotting the emission intensity
at 305 nm against time. (b) Fluorescence phase diagram obtained by plotting
I330nm against I305nm shows the multiple structural transitions accompanying
insulin aggregation. The experiment was done in 0.1% HCl (pH 1.9) at
60C, with continuous stirring at 120 rpm.spectrum of Tyr in fibrillated insulin solutions showed the
same peaks observed in a freshly prepared sample, though
considerably diminished in intensity. This reaffirmed that
Tyr residues present in the insulin fibrils were nonhydro-
gen-bonded. Indeed, early studies by Waugh showed that
the conversion of native insulin molecules into fibrillar aggre-
gates did not involve chemical modification (38). Recent
studies using a-synuclein at pH 7.4 found that whereas there
was no evidence of dityrosine formation during fibrillation,
this covalent linkage was observed in the soluble aggregates
present after fibrillation was complete (39).
Temperature effect on bovine insulin
Thermal denaturation and renaturation of bovine insulin and
associated changes in its structure were studied by fluores-
cence and CD spectroscopy; conducted independently but
under comparable experimental conditions. The aim was to
further understand the sensitivity and, hence, applicability
of intrinsic Tyr fluorescence in studying conformational
and structural changes in bovine insulin during aggregation.
CD spectra in the far-ultraviolet wavelength range (typically
from ~190 to 250 nm) provide useful information on the
secondary structure of proteins (40), whereas intrinsic
protein fluorescence (in this case Tyr fluorescence) provides
basic information on the dynamics of structural reorganiza-
tion in protein molecules (35). At ambient temperature, the
far-UV spectrum of native insulin showed two negative
peak intensities at 209 nm and 222 nm, typical of an
a-helical secondary structure, and these intensities have
been used in studying insulin denaturation (41).
Thermal unfolding of the helical segments of insulin was
monitored using the ellipticity at 222 nm, whereas Tyr fluo-
rescence emission was monitored from 280 to 500 nm on
excitation at 276 nm (the intensity at lmax 303 nm is shown)
(Fig. 4 a). The far-UV spectrum shows that temperature
elevation results in a significant decrease in the negative
intensity at 222 nm, indicating a loss of helical structure.
Such conformational changes obviously would affect the
local environment, especially of the three Tyr residues resi-
dent in the helical regions of bovine insulin (6). True to
this, the Tyr emission intensity at 303 nm showed a 73%
decrease as a function of temperature on heating from
10C to 95C. It has been established that the emission
lmax of Tyr is independent of temperature (31) and the loca-
tion of nonhydrogen-bonded Tyr in a protein’s hydrophobic
interior or a-helical segment enhances its quantum yield
(or intensity) (42). Therefore, the observed decrease in Tyr
fluorescence intensity is attributable to effective Tyr-
quencher interactions facilitated by 1), heat-induced
structural disorder of the native state via perturbation of
intra-/intermolecular interactions (including hydrogen
bonding, van der Waals, hydrophobic, and electrostatic inter-
actions); and 2), enhanced dynamic mobility of the entire
protein matrix, dictated by solvent viscosity (29).Biophysical Journal 97(9) 2521–2531
2526 Bekard and DunstanFIGURE 4 Thermal denaturation of bovine insulin (0.2 mg/mL) as
detected by fluorescence and CD spectroscopy. (a) Decrease in Tyr emission
intensity at 303 nm and loss of secondary structure on heat denaturation
(open triangles). The reverse is observed on renaturation (open circles).
The temperature range was between 10C and 95C, and data were col-
lected at 5C intervals. Phase diagrams obtained from fluorescence (b)
and CD (c) data reveal the existence of structural intermediates on thermal
denaturation of insulin. Error bars indicate the 5SD of duplicates of each
experiment.Biophysical Journal 97(9) 2521–2531Both fluorescence and CD spectra show that the major
transition occurred between 25C and 80C. It is important
to note that the fluorescence spectra also show that the tran-
sitions involved are completely reversible, as the emission
intensities at various temperatures were restored on renatur-
ation. However, the CD spectra on renaturation show ~13%
loss in the native helical content (with reference to the inten-
sities at 10C) which suggests that some molecular interac-
tions were permanently damaged on denaturation, hence
preventing the complete refolding of insulin on cooling.
The fluorescence and CD data were further analyzed using
phase plots (Fig. 4, b and c, respectively). Fluorescence
phase plots were obtained by plotting I330nm against I303nm,
whereas CD phase plots were generated using the negative
ellipticities at q209nm and q222nm. We chose the peak wave-
lengths from the CD spectra, as these have been successfully
used in building phase plots to distinguish structural transi-
tions during insulin fibrillation (30). Both plots show three
linear segments, indicative of the existence of two interme-
diate states during the transition from native to temporarily
denatured insulin. A closer analysis of the plots shows that
whereas the linear segments of the fluorescence data span
10–25C, 30–55C, and 55–95C, those of the CD data
span 10–45C, 45–70C, and 70–95C. The difference in
the temperature range of the linear segments for the two
probes indicates that they differ in their sensitivity to struc-
tural changes in native insulin, and hence can be applied as
complementary techniques in studying insulin denaturation.
The initial transition (10–25C) in the fluorescence plot
may be attributed to a decrease in viscosity of the protein
matrix enhancing intramolecular collisions between excited
Tyr side chains and neighboring quenchers. The CD plot
shows no major conformational change within this tempera-
ture range. The second fluorescence transition (30–55C)
corresponds to the dissociation of dimers into monomers
and the emergence of the so-called heat-induced molten
insulin globule, which is the major species in solution at
~55C (43). It is noteworthy that this is the first major
conformational transition detected by CD (at ~45C), reach-
ing a maximum at ~70C. Indeed, differential scanning
calorimetry scans of bovine insulin (pH 1.9) showed an
endothermic transition midpoint at 60C (44). Therefore,
transitions beyond 55C can be ascribed to thermal unfold-
ing of monomeric insulin into an unstructured, aggrega-
tion-prone intermediate.
It is worth noting that the tertiary/quaternary structure of
bovine insulin monitored at q278nm (typical Tyr signature)
showed complex structural transitions occurring at tempera-
tures similar to that observed in the fluorescence phase plots
(data not shown). However, the data were not considered in
detail, because the peak negative intensity at 278 nm was
weak (near zero), indicating a lack of native tertiary interac-
tions. We attribute this weakness to the low insulin concen-
tration used in this study. This is consistent with the notion
that insulin adopts a less rigid structure at low
Bovine Insulin Fibrillation 2527concentrations, with highly mobile aromatic side chains that
show weak intensity. Disulfide bonds, three of which are
present in insulin, are known to contribute significantly to
the absorption in the near-UV region, which further compli-
cates the interpretation of spectral data obtained from that
region (45,46).
DISCUSSION
The use of fluorescent probes has found wide application in
studies of the structure and dynamics of proteins (31).
In vitro studies of protein aggregation have employed the
histological dye Thioflavin T to detect amyloid fibrils and
the hydrophobic dye ANS to establish the existence of
partially folded intermediates on the pathway to protein fibril-
lation (47,48). It is interesting to note that structural changes
in proteins can be detected via intrinsic protein fluorescence
(31); hence, this feature can be applied (in addition to other
techniques) in resolving the complex structural transitions
involved in protein aggregation. Themain advantage of using
intrinsic protein fluorescence is that it provides information on
the dynamics associated with protein aggregation at the
molecular level. To probe the kinetics of insulin fibrillation
via intrinsic fluorescence, it is important to appreciate the
underlying cause of the observed Tyr fluorescence quenching
and how this feature is related to the fibrillating protein.
Quenching of Tyr ﬂuorescence during insulin
aggregation
There are several possible catalysts for the observed Tyr
fluorescence quenching preceding insulin fibrillation: 1),
protolysis of the phenol group of Tyr when it interacts
with solvent molecules and/or amino acid side chains, which
can act as proton donors or acceptors or as hydrogen-
bonding partners; 2), resonance energy transfer from Tyr
to Tyr, Tyr to tyrosinate, Tyr to ANS, or Tyr to ThT; 3),
interactions between the excited chromophore and hydrated
peptide carbonyl groups; or 4), interactions between the
excited chromophore and cystine groups (49). The occur-
rence of any of these mechanisms is dependent on the local
environment of both the ground and singlet excited states of
Tyr residues in the protein matrix, including their proximity
to and interactions with quenchers.
The ionizable groups in bovine insulin are fully protonated
at pH 1.9. Since excited Tyr residues have a nominal pKa of
4.2, deprotonation of the hydroxy group and subsequent
formation of tyrosinate or Tyr-carboxylate hydrogen bonds
is theoretically impractical. Our results show that the emis-
sion lmax of Tyr is constant at 305 nm, although considerably
diminished in intensity, even after insulin fibrillation. Further
supporting this finding, the kinetic experiments discounted
the likelihood of transient hydrogen bonds existing between
Tyr residues and solvent molecules, the peptide carbonyl, or
neighboring carboxyl groups. This was expected as the rateof depopulation of the excited state by emission is
much faster than depopulation by excited-state protolysis
(37). Taken together, the observed Tyr fluorescence quench-
ing during insulin aggregation is unlikely to be due to protol-
ysis of the phenolic chromophore in the ground or excited
states.
The presence of multiple Tyr and Phe residues in bovine
insulin raises the possibility of resonance energy transfer
from Phe to Tyr and between adjacent Tyr residues.
However, the 276-nm excitation wavelength used in this
study would minimize the amount of light absorbed by
Phe residues, because these residues show maximum absorp-
tion at 258 nm. The radii of globular proteins are reported to
range between 15 A˚ and 30 A˚, which is within acceptable
limits for efficient energy transfer between donor and
acceptor molecules (50). It is anticipated, therefore, that
the average distance between Tyr groups in insulin, given
as 16.57 A˚, will permit efficient intertyrosine resonance
energy transfer (28). Indeed, fluorescence-polarization
measurements of insulin have established the occurrence of
intertyrosine energy transfer (51). It is also expected that
Phe residues will contribute to the overall quantum yield
of Tyr fluorescence. Resonance energy transfer between
Tyr and ANS has been reported (52), and we have also
observed that on excitation at 276 nm, the emission spectrum
of Tyr in insulin overlaps with the excitation spectrum of
unbound ThT (Bekard, I. B. and Dunstan, D. E., unpublished
work). Taken together, it can be deduced that the initial
structural reorganization preceding insulin fibrillation brings
aromatic residues into proximity, hence facilitating energy
transfer between donor and acceptor molecules within the
protein matrix and in solution. A probable consequence of
this dynamic association is the observed quenching of Tyr
fluorescence.
Insulin contains three native disulfide bonds that have
been established as strong quenchers of intrinsic fluores-
cence (31). These covalent bonds are known to be highly
hydrophobic and shielded from the aqueous environment
in native insulin (7,53–55). Tyr is partially hydrophobic,
and three out of the four Tyr residues in bovine insulin are
located in hydrophobic pockets and involved in hydrophobic
interactions resulting in various association states of the
protein (13). For this reason, interactions between Tyr resi-
dues and disulfide bonds can only occur upon exposure of
hydrophobic groups to the solvent. The results show that
ANS fluorescence enhancement, which indicates the pres-
ence of solvent-exposed hydrophobic regions, occurs in
sync with Tyr fluorescence quenching (Fig. 1). This is a clear
indication that the ANS binding sites are in proximity to
most of the Tyr residues (48), and that exposure of these
hydrophobic regions makes Tyr accessible to quenchers. It
should be noted that disulfide bonds, which are strong
quenchers of intrinsic protein fluorescence, also become
solvent-accessible upon insulin denaturation, and their inter-
action with excited Tyr residues is greatly enhanced.Biophysical Journal 97(9) 2521–2531
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in the absence of dyes (Fig. 3 a and Fig. S1 a). This suggests
that its occurrence is predominantly a result of intra-/inter-
molecular singlet-singlet energy transfer between adjacent
Tyr residues (51) and, most probably, effective contacts
between excited singlet Tyr residues and cystinyl side chains
(31). The frequency of these interactions is determined by
the heat- and agitation-induced fluidity of the protein matrix
resulting from the disruption of hydrophobic pockets and
other stabilizing forces that maintain the native protein
(56). This is buttressed by the temperature dependence of
tyrosine fluorescence, giving ample evidence that the con-
tact quenching mechanism is collisional and not static. The
mechanism of Tyr fluorescence quenching by cystine is
debated. The suggested possibilities include deactivation of
the excited-state molecules via internal conversion or
enhanced intersystem crossing to the triplet state (57).
In summary, the start of Tyr fluorescence quenching
signifies the emergence of solvent-exposed hydrophobic
groups, hence partially folded intermediates, in solution.
Insulin ﬁbrillation detected via Tyr ﬂuorescence
In 0.1% HCl (pH 1.9), insulin is predominantly dimeric. At
60C, however, the equilibrium favors the monomeric state
and protein denaturation is known to free phenolic groups
bound in the native protein. From Figs. 1 and 3 a (inset),
the initial 2 h preceding Tyr fluorescence quenching is the
time taken for the dissociation of existing dimers into mono-
mers and disruption of the stabilizing forces of native insulin
monomers. The result is thermal and agitation-induced dena-
turation of monomeric insulin and consequent exposure of
hydrophobic regions to the aqueous environment. The start
of Tyr fluorescence quenching at ~2 h indicates the emer-
gence of a new structural species, a partially unfolded inter-
mediate, in solution, a conclusion that is buttressed by the
results of ANS experiments. This is consistent with reports
that partially folded intermediates precede insulin fibrillation
(23). The light-scattering profile (Fig. 1) shows that this new
structural species associates rapidly into large (oligomeric)
aggregates. The Tyr fluorescence phase plot (Fig. 3 b)
equally detects these aggregates evolving at ~3 h, reaching
a maximum concentration at ~12 h. Mass spectrometry
studies on amyloidogenic insulin samples incubated at
high temperatures revealed that the dissociation of soluble
higher oligomers (e.g., dimers) is followed by the formation
of high-molecular-weight aggregates, from which fibrils
evolve (33).
The emergence of these oligomeric aggregates is attribut-
able to an interplay of electrostatic and hydrophobic interac-
tions that allow self-association of denatured monomers. For
example, the chloride ions present in the solvent mask the net
positive charge on native insulin at pH 1.9, allowing the coa-
lescence of monomers, via hydrophobic interactions between
partially unfolded intermediates, to form a fibril-competentBiophysical Journal 97(9) 2521–2531nucleus. This effect of chloride ions is purported to con-
tribute to the precipitation of insulin into a dense network
of fibrils (6). The absence of hydrogen-bonded Tyr residues,
coupled with the insulin-solvent charge interactions at pH
1.9, supports the hypothesis that the attractive force driving
the association of partially unfolded monomers into oligo-
mers at 60C is hydrophobic in nature. ThT fluorescence
begins to increase partway (~5 h, Fig. 1) through the forma-
tion of these intermediates, which implies that the oligomers,
so formed, begin to polymerize into fibrillar aggregates, and
these aggregates become the dominant structural species at
22 h. The saturation of Tyr fluorescence quenching at
~12 h (Fig. 3 a, inset) indicates that the majority of Tyr resi-
dues, hence hydrophobic regions, become solvent-exposed
at that time. ThT fluorescence reaches equilibrium after
18 h, which suggests that most of the fibril-competent nuclei
are consumed by mature fibrils at that time. Based on these
results, it is clear that the major structural changes during
insulin aggregation can be detected via Tyr fluorescence.
The sequence of structural changes accompanying insulin
fibrillation, and the probes sensitive to each structural transi-
tion, as observed in this study, are summarized in Fig. 5. It is
noteworthy that the phase plots obtained from intrinsic Tyr
fluorescence are sensitive to these structural changes (Fig. 3 b).
Biophysical differences in insulin ﬁbrils formed
in the presence or absence of dyes
The AFM images show that the physical appearance of
insulin fibrils differs depending on the dye present. Insulin
fibrils formed in the absence of ANS or ThT were finer,
whereas fibrils formed in the presence of dyes appeared
thicker, indicating a higher degree of association. In the
case of ANS, the sulphonate group of the dye is negatively
charged at pH 1.9 and in complement with chloride ions
may mask the net positive charge on insulin, leading to
a more significant precipitation of fibrils. ThT, on the other
hand, is known to bind along cavities running parallel to
insulin fibrils, hence contributing to the overall fibril struc-
ture. Indeed, x-ray diffraction studies have confirmed
increased morphological variation in insulin fibrils formed
in the presence of ThT compared to those formed in the
absence of the dye (47). Such structural discrepancies, in
addition to the residual a-helical structure known to exist
in fibrillated insulin, may account for the differences in CD
spectra for fibrils formed in the presence and absence of
ThT/ANS. It is also likely that the dyes, aside from influ-
encing the fibril structure, also perturb the electron cloud
of insulin amide chromophores responsible for the far-UV
CD signal; resulting in the observed differences in intensity
and peak position (58). It is noteworthy that the techniques
applied here do not allow a firm conclusion to be drawn
from these observations. Further analysis using techniques
such as x-ray diffraction is necessary for concrete compar-
ison of fibrils formed under the different conditions.
Bovine Insulin Fibrillation 2529FIGURE 5 Schematic representation of the sequence of
on-pathway structural changes accompanying insulin
fibrillation.Relevance of monitoring insulin aggregation via
its intrinsic ﬂuorescence
The nonintrusive but sensitive nature of intrinsic protein
fluorescence makes it a versatile tool used in concert with
other protein aggregation probes (especially extrinsic
probes) to gain additional information on the structural
changes associated with insulin deformation and aggrega-
tion. The merit in obtaining such critical information from
the protein itself cannot be overemphasized. For example,
it affords the advantage of directly monitoring changes that
occur in the peptide-hormone at the molecular level during
aggregation, giving concrete details on the early events
preceding fibrillation. This approach is suitable for real-
time fluorescence studies conducted in situ. It is noteworthy
that the light-scattering technique used in this study only
provides qualitative evidence of the association of deformed
insulin monomers into larger aggregates. However, its sensi-
tivity to the size increase of insulin aggregates in solution
makes it a suitable complementary probe in monitoring
protein aggregation.
CONCLUSION
We have shown that intrinsic Tyr fluorescence can be used
to resolve the complex structural modifications associated
with insulin fibrillation. The observed Tyr fluorescence
quenching during insulin aggregation is attributable to
energy transfer between Tyr residues and acceptor mole-
cules (including adjacent Tyr residues, ThT, and ANS)
and the likely repetitive collisions between exposed Tyr
residues and indole fluorescence quenchers such as thedisulfide bonds present in native insulin. There was no evi-
dence of tyrosinate or dityrosine formation during insulin
aggregation.
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